Pharmafit Provence

TRB Chemedica

HYLOVIS GEL MULTI Sol oculaire without conservateur Fl/15ml

CIP / EAN code: 3760054331037

Product information from VIDAL.

Read the product information
Back to the catalogue

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Parapharmacy
Update of 25/02/2026

CE HYLOVIS® GEL MULTI eye solution
sodium hyaluronate at 0,3 %

Forms and presentations 

Sterile hydrogel for topical ophthalmic use:  Multidose bottle of 15 ml without preservative (EAN 3760054331037).

Composition 

Sodium hyaluronate: 3,0 mg/ml; sodium, potassium, magnesium, calcium chlorides; disodium phosphate; sodium citrate; purified water. Without preservative agent. The solution is hypotonic.

Properties 

Hylovis Gel Multi contains sodium hyaluronate, a natural polymer also present in the structures of the human eye. The particular physical characteristics of sodium hyaluronate give Hylovis Gel Multi its viscoelastic and water-retention properties. Hylovis Gel Multi thus forms a stable film on the surface of the eye that is only very slowly removed by blinking of the eyelids. Hylovis Gel Multi thus combines a prolonged effect with maximum comfort.
Due to its particular composition, Hylovis Gel Multi is very well tolerated.
Hylovis Gel Multi does not contain a preservative agent.

Indications 

Moderate and severe sensations of dry eye.

Directions for use 

  • Remove the tamper-evident ring before the first administration.
  • Remove the protective cap.
  • Tilt the head back and position the tip of the bottle above the eye to be treated.
  • Pull the lower eyelid down with the index finger of one hand.
  • Press on the body of the bottle and a drop of Hylovis Gel Multi will flow out easily.
Unless otherwise recommended, instil 1 to 2 drops of Hylovis Gel Multi into the eye as often as necessary. A few blinks of the eyelids will ensure even distribution of the solution over the ocular surface as a transparent and durable film.
Hylovis Gel Multi can be used while wearing contact lenses (rigid or soft).

Contraindications 

Hypersensitivity to any of the components of the product.

Precautions for use 

Do not touch the tip of the opened bottle and do not touch the surface of the eye with the tip of the bottle.

Replace the protective cap of Hylovis Gel Multi after use.

Do not use Hylovis Gel Multi if the bottle is damaged.

Hylovis Gel Multi can be used for up to 6 months after first use. Any solution not used within 6 months of opening must be discarded. Otherwise, sterility is no longer guaranteed, and this may be associated with a risk of infection.

Store below 30 °C. Do not freeze.

Do not use Hylovis Gel Multi after the expiry date indicated on the bottle and box.

If symptoms persist while using Hylovis Gel Multi, consult a doctor.

Keep out of reach of children.

Adverse effects
In very rare cases, temporary disturbances such as irritation of the conjunctiva, a foreign body sensation, redness or a burning sensation of the eye, as well as momentarily blurred vision may occur.
Concomitant treatment with risk of interaction:
Do not administer Hylovis Gel Multi at the same time as other medicinal products or ophthalmic products, as it may alter their effects.

ADMINISTRATIVE INFORMATION 

LPPR rate:
8,75 euros (LPPR code 1125637).
Maximum retail selling price:12,14 euros.
AAD Service Code.
 
Indications covered:
Symptomatic treatment of dry eye with keratitis or dry keratoconjunctivitis as third-line therapy after failure of low-viscosity artificial tears and gels (carbomer type).
In this indication, the use of Hylovis Gel Multi is not indicated in patients wearing contact lenses.
 
Prescribing and use conditions:
Within the framework of the indication approved under the LPPR for products of this type:
- prescription by an ophthalmologist after diagnosis of keratitis or dry keratoconjunctivitis, in particular by a colorimetric test performed with a slit lamp;
- initial prescription not to exceed 6 months of treatment. At the end of this period, reassessment, ideally by an ophthalmologist, for a possible renewal of the prescription.

Medical device, class IIb CE 0123.
 
Manufacturer: TRB Chemedica AG, Otto-Lilienthal-Ring 26, 85622 Feldkirchen/München, Germany.

TRB CHEMEDICA SAS
ArchParc, ActiTech 4
60, avenue Marie-Curie
CS 40218. 74160 Archamps
Tel: 04 50 95 09 00
https://trbchemedica.fr/

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.